Publications by authors named "Alexander Desuki"

Claim this Profile
P
Pathogenic Neurofibromatosis type 1 gene variants in tumors of non-NF1 patients and role of R1276.
Mareike Selig, Swanhild Lohse, Sara Elahi, Nils Hartmann, Stefanie Deckert, Alexander Desuki

FEBS Open Bio· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.
Lino Möhrmann, Lysann Rostock, Maximilian Werner, Małgorzata Oleś, Jonas S Arnold, Alexander Desuki

Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision oncology - Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology.
Damian T Rieke, Michael Bitzer, Annalen Bleckmann, Alexander Desuki, Thomas Ernst

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Do German Molecular Tumor Boards Recommend in Patients with PIK3CA-Mutated Tumors? Launch and First Results from the German Transsectoral Molecular Tumor Board Exchange Platform Deutschland.
Ina Pretzell, Alexander Desuki, Annalen Bleckmann, Sonja Loges, Anke Reinacher-Schick

Oncol Res Treat· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.
Andreas Mackensen, John B A G Haanen, Christian Koenecke, Winfried Alsdorf, Eva Wagner-Drouet, Alexander Desuki

Nat Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of corneal findings and their interrelation with hematological findings in monoclonal gammopathy.
Mohammad Al Hariri, Markus Munder, Walter Lisch, Alexander K Schuster, Eva-Marie Fehr, Alexander Desuki

PLoS One· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of doxorubicin-induced cardiomyopathy with low-dose sacubitril/valsartan: a case report.
Elisabeth Bell, Alexander Desuki, Susanne Karbach, Sebastian Göbel

Eur Heart J Case Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of cardiac amyloidosis on outcomes of patients hospitalized with heart failure.
Sebastian Göbel, Lukas Hobohm, Alexander Desuki, Tommaso Gori, Thomas Münzel

Eur J Intern Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.
Lino Möhrmann, Maximilian Werner, Małgorzata Oleś, Andreas Mock, Sebastian Uhrig, Alexander Desuki

Nat Commun· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
cbpManager: a web application to streamline the integration of clinical and genomic data in cBioPortal to support the Molecular Tumor Board.
Arsenij Ustjanzew, Alexander Desuki, Christoph Ritzel, Alina Corinna Dolezilek, Daniel-Christoph Wagner

BMC Med Inform Decis Mak· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations.
Felix C Saalfeld, Carina Wenzel, Petros Christopoulos, Sabine Merkelbach-Bruse, Timm M Reissig, Alexander Desuki

J Thorac Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases.
Alexander Desuki, Frank Staib, Ines Gockel, Markus Moehler, Hauke Lang

Can J Gastroenterol Hepatol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma.
Olaf Beck, Claudia Paret, Alexandra Russo, Jürgen Burhenne, Margaux Fresnais, Alexander Desuki

Cancers (Basel)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation.
Nicole Stadler, Astrid Hasibeder, Pamela Aranda Lopez, Daniel Teschner, Alexander Desuki

Haematologica· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hematologic Definition of Monoclonal Gammopathy of Undetermined Significance in Relation to Paraproteinemic Keratopathy (An American Ophthalmological Society Thesis).
Walter Lisch, Joanna Wasielica-Poslednik, Tero Kivelä, Ursula Schlötzer-Schrehardt, Jens M Rohrbach, Alexander Desuki

Trans Am Ophthalmol Soc· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: The Hematologic Definition of Monoclonal Gammopathy of Undetermined Significance in Relation to Paraproteinemic Keratopathy (An American Ophthalmological Society Thesis).
Walter Lisch, Joanna Wasielica-Poslednik, Tero Kivelä, Ursula Schlötzer-Schrehardt, Jens M Rohrbach, Alexander Desuki

Trans Am Ophthalmol Soc· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis